A reminder of the pedigree we have working on this. https://www.linkedin.com/in/axel-hoos-48b4b013 I’m opening up a book. Who’s it going to be? GlaxoSmithKline 2/1 Roche 4/1 BristolMyersSquib 7/1 Thoughts on odds and others welcome.
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
I88 Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”
